Dr. Christopher R. Loiselle, MD

Dr. Loiselle practices at Swedish Cherry Hill Campus in Seattle, Washington, part of Providence Health & Services.

Dr. Loiselle's NPI, 1225259187, was assigned on May 1, 2007. Dr. Loiselle graduated from Johns Hopkins University School of Medicine in 2006. Dr. Loiselle holds Washington license MD60101794.

Dr. Loiselle's primary practice is Swedish Cherry Hill Campus, at 500 17th Avenue, Seattle, WA 98122 in King County. The practice phone is (206) 320-2000.

Dr. Loiselle's primary practice is Swedish Cherry Hill Campus in Seattle, Washington, part of Providence Health & Services. Dr. Loiselle is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Loiselle to 1 more hospital, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Loiselle practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Loiselle's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Loiselle is licensed in Washington.

CMS data shows 1,784 Medicare services from Dr. Loiselle across 15 procedure codes in 2024, for 164 Medicare patients. Medicare paid $139,350 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Loiselle in 2024. The largest group is 75 to 84, with 67 patients. 65% of them have high cholesterol, and 52% have cancer. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Loiselle's median patient age at 67, with 61% women.

In 2024, Dr. Loiselle wrote 50 Medicare Part D claims for 27 patients. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $163 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Loiselle for performance year 2024, reported as part of a group. Dr. Loiselle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Loiselle as offering telehealth.

Dmand AI links 4 papers to Dr. Loiselle, published from 2016 to 2023. The most frequent topics are Axilla, Breast Neoplasms and Lymphatic Metastasis. Dr. Loiselle's most frequent co-authors are Peter Reist Eby, MD, Kimberly H. Allison, MD and Ranjit S. Bindra, MD, PhD.

CMS Open Payments shows 101 general payments to Dr. Loiselle from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. Accuray Incorporated paid the most, $57,853.

Dr. Loiselle graduated from Johns Hopkins University School of Medicine in 2006.